Advertisement
YOU ARE HERE: LAT HomeCollectionsUrology
IN THE NEWS

Urology

CALIFORNIA | LOCAL
May 3, 1987
"Su Doctor," a free referral service designed to link Spanish-speaking patients with Spanish-speaking physicians, is being offered by Doctors Hospital of Santa Ana and Santa Ana Hospital Medical Center. By calling 1-800-44-DOCTOR weekdays and Saturdays, a caller can be referred to a Spanish-speaking doctor in areas of Orange County and Whittier.
Advertisement
BUSINESS
January 6, 2000
Cryosurgery, which uses extremely cold temperatures to freeze and destroy cancerous cells, was 97% effective on men who had recurrences of prostate cancer, according to the results of a clinical study to be published today in the journal Urology. The study, sponsored by Endocare Inc. in Irvine, found that 42 of the 43 men in the clinical trial have been essentially disease-free since undergoing cryosurgery about two years ago. Cryosurgery has been used to treat first-time cancer patients.
BUSINESS
August 19, 1996
Trimedyne Inc. said the U.S. Patent and Trademark Office upheld the validity of all of the claims on its laser patent. In 1995, Laser Industries Ltd. filed a petition with the patent office asking that Trimedyne's patent be reexamined. The patent gives Trimedyne the ability to manufacture other lasers with higher power and unique energy delivery capabilities, the company said.
CALIFORNIA | LOCAL
May 15, 2007 | From Times Staff and Wire Reports
Dr. John K. Lattimer, 92, a renowned urologist and ballistics expert who was chosen by President Kennedy's family to examine evidence in his assassination, died Thursday at a hospice near his home in Englewood, N.J. A professor and chairman of the urology department at Columbia University's College of Physicians and Surgeons for 25 years, Lattimer was known for helping establish pediatric urology as a discipline and developed a cure for renal tuberculosis.
BUSINESS
June 29, 2004 | From Bloomberg News
Watson Pharmaceuticals Inc., the largest U.S. maker of birth-control pills, cut second-quarter sales and profit estimates Monday and said it would fire half of its sales force. Its shares slid 15% on the news. The Corona firm said contraceptive sales fell short of forecasts because of increased competition from rivals like Barr Pharmaceuticals Inc. Watson projected it would earn 31 cents to 33 cents in the second quarter, down from its previous estimate of 50 cents to 52 cents.
NEWS
December 26, 1988 | Steve Emmons, Times Staff Writer
Garo M. Tertzakian was born in Lebanon in 1949 to an Armenian family that had fled the Turkish persecution of Armenians during World War I. The grandson of a tobacconist and the son of a tailor, Tertzakian graduated as a medical doctor from the American University of Beirut and trained in general surgery at the Medical College of Ohio at Toledo. He served his residency in urology at UC Irvine Medical Center, where he remains an assistant professor of urology specializing in kidney transplants.
CALIFORNIA | LOCAL
December 26, 1988 | Steve Emmons, Times Staff Writer
Garo M. Tertzakian was born in Lebanon in 1949 to an Armenian family that had fled the Turkish persecution of Armenians during World War I. The grandson of a tobacconist and the son of a tailor, Tertzakian graduated as a medical doctor from the American University of Beirut and trained in general surgery at the Medical College of Ohio at Toledo. He served his residency in urology at UC Irvine Medical Center, where he remains an assistant professor of urology specializing in kidney transplants.
CALIFORNIA | LOCAL
July 12, 2001 | ERIC MALNIC, TIMES STAFF WRITER
A three-year, $50-million program to help uninsured men throughout the state receive treatment for prostate cancer was announced Wednesday by UCLA. Regional treatment sites opened Wednesday at the UCLA Medical Center in Westwood, UC Medical School in San Francisco and UC Davis near Sacramento. Treatment sites at UC Irvine and UC San Diego are scheduled to open next year.
Los Angeles Times Articles
|